Sone Capital Management LLC acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,143 shares of the semiconductor company’s stock, valued at approximately $1,402,000.
A number of other hedge funds have also bought and sold shares of SNPS. Sankala Group LLC purchased a new position in shares of Synopsys during the 4th quarter worth about $25,000. Elevation Wealth Partners LLC raised its position in Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. Osbon Capital Management LLC bought a new stake in Synopsys in the second quarter worth about $25,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys in the fourth quarter worth about $28,000. Finally, IMG Wealth Management Inc. purchased a new position in shares of Synopsys during the second quarter valued at approximately $28,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of SNPS stock opened at $394.51 on Tuesday. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The stock has a fifty day simple moving average of $418.53 and a two-hundred day simple moving average of $439.92. The stock has a market capitalization of $75.54 billion, a price-to-earnings ratio of 91.32, a P/E/G ratio of 2.34 and a beta of 1.23.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on SNPS shares. BNP Paribas Exane increased their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Benchmark restated a “buy” rating on shares of Synopsys in a report on Wednesday, August 19th. Bank of America upped their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Morgan Stanley reduced their target price on Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 19th. Finally, Berenberg Bank set a $633.00 target price on Synopsys in a research report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $563.59.
View Our Latest Stock Analysis on SNPS
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
